Exercise clinical trials

Explore recruiting exercise clinical trials.

Recruiting exercise studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Exercise trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The POST-PRANDIAL HYPO-AVOID STUDY Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People with Type 1 Diabetes

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

An open-label, prospective, single centre study of the effects of Riociguat on RIght VEntricular size and function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Phase IV, single-center, double blind, randomized, crossover, placebo-controlled study, to investigate the effect of dual bronchodilation with umeclidinium/vilanterol on patients with COPD, hyperinflation and heart failure

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Measuring Oncological Value of Exercise and Statin (MOVES)

Finland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity (OligoTreat)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Targeting mTOR with everolimus and/or physical training for preventing postmenopausal bone loss and accelerated skeletal aging. The RapaLoad study.

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Exercise trials by city

Exercise in Toronto Exercise in Vancouver Exercise in Montreal Exercise in Calgary Exercise in Edmonton Exercise in Ottawa Exercise in Winnipeg Exercise in Quebec City Exercise in Hamilton Exercise in Kitchener Exercise in London Exercise in Halifax Exercise in New York Exercise in Los Angeles Exercise in Chicago Exercise in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease